Ensign Peak Advisors
RCKT icon

Ensign Peak Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Ensign Peak Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,210
Closed -$131K – 2124
2022
Q3 		$131K Buy
8,210
+480
+6% +$7.49K ﹤0.01% 2014
2022
Q2 		$106K Hold
7,730
– – ﹤0.01% 1952
2022
Q1 		$123K Hold
7,730
– – ﹤0.01% 1991
2021
Q4 		$169K Buy
+7,730
New +$211K ﹤0.01% 1960
2021
Q2 		– Sell
-32,021
Closed -$1.42M – 1850
2021
Q1 		$1.42M Buy
32,021
+8,667
+37% +$476K ﹤0.01% 1273
2020
Q4 		$1.28M Buy
23,354
+5,300
+29% +$193K ﹤0.01% 1292
2020
Q3 		$413K Buy
+18,054
New +$445K ﹤0.01% 1577

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return